Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Boehringer Ingelheim
Mallinckrodt
Express Scripts
Merck

Last Updated: May 27, 2022

LEVOXYL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Levoxyl patents expire, and when can generic versions of Levoxyl launch?

Levoxyl is a drug marketed by King Pharms and is included in one NDA. There are three patents protecting this drug.

This drug has twenty-six patent family members in nine countries.

The generic ingredient in LEVOXYL is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Levoxyl

A generic version of LEVOXYL was approved as levothyroxine sodium by MYLAN on June 5th, 2002.

  Try it Free

Drug patent expirations by year for LEVOXYL
Drug Prices for LEVOXYL

See drug prices for LEVOXYL

Drug Sales Revenue Trends for LEVOXYL

See drug sales revenues for LEVOXYL

Recent Clinical Trials for LEVOXYL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Hospital of PhiladelphiaN/A
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)N/A

See all LEVOXYL clinical trials

US Patents and Regulatory Information for LEVOXYL

LEVOXYL is protected by three US patents.

Patents protecting LEVOXYL

Levothyroxine compositions and methods
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Methods of administering levothyroxine pharmaceutical compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF USE OF ADMINISTERING LEVOTHYROXINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-011 May 25, 2001 AB1,AB3 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-010 May 25, 2001 AB1,AB3 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-011 May 25, 2001 AB1,AB3 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-010 May 25, 2001 AB1,AB3 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-001 May 25, 2001 AB1,AB3 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-006 May 25, 2001 AB1,AB3 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
King Pharms LEVOXYL levothyroxine sodium TABLET;ORAL 021301-008 May 25, 2001 AB1,AB3 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LEVOXYL

International Patents for LEVOXYL

See the table below for patents covering LEVOXYL around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 03061557 See Plans and Pricing
World Intellectual Property Organization (WIPO) 02064093 See Plans and Pricing
Norway 20033636 See Plans and Pricing
South Korea 20040100835 See Plans and Pricing
Canada 2438641 See Plans and Pricing
Mexico PA03007338 FABRICACION DE TABLETAS DE HORMONA TIROIDEA QUE TIENEN CANTIDADES CONSISTENTES DE LA PORCION ACTIVA. (MANUFACTURE OF THYROID HORMONE TABLETS HAVING CONSISTENT ACTIVE MOIETY AMOUNTS.) See Plans and Pricing
Brazil 0207297 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Moodys
Express Scripts
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.